A Swiss team has developed a reliable blood test for younger, live cows. Now it is looking for investment to develop a test for Creutzfeldt-Jakob disease in humans.

IP2IPO Group, which specialises in commercialising university technology, has made an exclusive 25-year deal with the University of Bristol to form spin-out companies from the university. Analysts greeted the deal as a boost for the company.

Microsoft is to open more research centres in Europe, in a move to step up its research collaboration and boost students' interest in the technology field.

"Anything that won't sell, I don't want to invent. Its sale is proof of utility, and utility is success." Thomas A. Edison (1847-1931).

A new Munich-based company that says its patented technologies can reduce household water consumption by 90 per cent on average is looking for more investment.

Every cloud has its silver lining. So if it wasn't for his daughter's diabetes, Anders Essen-Möller might not have sold his company and started Diamyd Medical AB.

On inventive Californians, technology transfer, how to approach the business press, and other insights into R&D management.

Two New Year's resolutions for the governments around the world that have managed to gum up the economic machinery behind technological development.

University tech transfer offices should stop trying to do the impossible, says Biofusion CEO David Baynes.

The European Commission's Clinical Trials Directive was meant to make trials more simple. But it looks as if the effect has been to stop many trials taking place at all.